ACHV

Achieve Life Sciences (ACHV)

About Achieve Life Sciences (ACHV)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Details

Daily high

$3.24

Daily low

$2.97

Price at open

$3.07

52 Week High

$5.59

52 Week Low

$2.84

Market cap

105.6M

Dividend yield

0.00%

Volume

488,513

Avg. volume

311,154

P/E ratio

-2.72

Achieve Life Sciences News